Drug Information

Drug General Information
Drug ID
D0M5JC
Former ID
DIB004147
Drug Name
BrevaRex
Synonyms
AIT (breast cancer), AltaRex; AIT (breast cancer), ViRexx; MAb AR-20.5; Vaccine (breast cancer), AltaRex; Vaccine (breastcancer), ViRexx; Vaccine (multiple myeloma), Altarex; Vaccine (multiple myeloma), ViRexx; Anti-idiotype induction therapy (breast cancer), AltaRex; Anti-idiotype induction therapy (breast cancer), ViRexx; Anti-idiotype induction therapy (cancer), Paladin; Anti-idiotype induction therapy (multiple myeloma), AltaRex; Anti-idiotype induction therapy (multiple myeloma), United; Anti-idiotype induction therapy (multiple myeloma), ViRexx
Drug Type
Vaccine
Indication Pancreatic cancer [ICD9: 140-199, 140-229, 157, 210-229; ICD10:C25] Phase 1/2 [546767]
Company
Tapimmune; mabvax therapeutics
Target and Pathway
Target(s) Mucin 1 Target Info [527298]
WikiPathways Hematopoietic Stem Cell Differentiation
References
Ref 546767Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010209)
Ref 527298Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity. Ann Oncol. 2004 Dec;15(12):1825-33.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.